YI

111

5.00

1.35+36.99%

Closed16:00 01/13 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.750/3.650

TODAY RANGE3.630-5.35

VOL541.05K

MARKET CAP43.34M

52 WEEK RANGE2.480-11.35

AVG VOL (3M)13.77K

% TURNOVER6.24%

TURNOVER--

P/E (TTM)-4.4057

% RANGE47.12%

EPS(TTM)-1.1349

P/E(FORWARD)23.75

P/B-0.4510

BVPS-11.0860

DIVIDEND--

P/S0.0217

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP23.16M

SHARES OUTSTANDING8.67M

NEXT EARNINGS03/18-03/23

FREE FLOAT4.63M

LOT SIZE1

EX-DATE01/24/2025

News

Press Releases

Financial Reports

Profile

Reuters·12/22/2025 17:00
NASDAQ TRADE HALT <YI.O> VOLATILITY TRADING PAUSE AT 12:00 PM
TipRanks·12/17/2025 11:27
111, Inc. Reports Q3 2025 Profitability amid Strategic Asset-Light Transition
Seeking Alpha·12/17/2025 08:00
111 Non-GAAP EPADS of -$0.20, revenue of $421.52M
Reuters·12/17/2025 07:22
Chinese healthcare platform 111 Inc's Q3 revenue drops amid model shift
Reuters·12/17/2025 06:00
111 Inc. Q3 total operating expenses fell 13.4% to CNY180.3 million
Reuters·12/17/2025 06:00
111 INC Q3 ADJUSTED NET INCOME RMB 1.1 MILLION
TipRanks·09/23/2025 03:50
111, Inc. Reports Q2 2025 Financial Results
TipRanks·09/17/2025 10:36
111, Inc. Reports Q2 2025 Financial Results Amid Market Challenges
Seeking Alpha·09/17/2025 06:40
111 Non-GAAP EPADS of -$0.40, revenue of $447.51M
Reuters·09/17/2025 06:02
111 Inc. Reports 53.6% YoY Increase in Marketing Promotional Products Sales Revenue; Operating Expenses Decrease 9.3% YoY
Reuters·09/17/2025 06:00
111 INC Q2 INCOME FROM OPERATIONS RMB 100 THOUSAND
Reuters·08/29/2025 10:11
111 Inc. Files Amendment to Annual Report for Fiscal Year 2024
TipRanks·07/21/2025 12:40
Three new option listings and ten option delistings on July 21st
TipRanks·06/24/2025 03:50
111, Inc. Reports Stable Q1 2025 Results
TipRanks·06/20/2025 10:35
111, Inc. Reports Q1 2025 Financial Results with Sustained Profitability

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.17%

824.19

Biogen Inc

BIIB

-3.95%

178.30

Amgen Inc

AMGN

-0.38%

324.30

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-15.96%

0.1680

Lilly Eli & Co

LLY

-0.40%

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

+0.96%

2.10

Johnson & Johnson

JNJ

+1.89%

213.69

Abbvie Inc

ABBV

+0.30%

220.69

Zoetis Inc

ZTS

-0.54%

124.64

Gilead Sciences Inc

GILD

-0.69%

121.76

Novo-Nordisk A/S

NVO

-0.38%

59.63

Bristol-Myers Squibb Co

BMY

+0.29%

55.93

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-0.57%

25.13

Sanofi FR

SNY

-0.84%

47.20

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.08%

141.71

Dr Reddys Labs

RDY

-2.00%

13.21

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.